Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: GemcitabineABRaxaneIRInotecanOXaliplatine-2 ×

GemcitabineABRaxaneIRInotecanOXaliplatine-2

This drug is selected. Its supporting articles are shown below.

GemcitabineABRaxaneIRInotecanOXaliplatine-21

Articles mentioning GemcitabineABRaxaneIRInotecanOXaliplatine-2

1 articles · page 1 of 1

GABRINOX-2 protocol: a French, prospective, multicentre, randomised phase II trial evaluating gemcitabine/nab-paclitaxel followed by FOLFIRINOX versus FOLFIRINOX alone as first-line treatment for metastatic pancreatic cancer

bmjopen · abstract · 2025-08-16 · 1 matching annotations

94.4%

gemcitabine GemcitabineABRaxaneIRInotecanOXaliplatine-2 GEMBRAX nab-paclitaxel Pancreatic adenocarcinoma FFX mPC FOLFIRINOX French National Agency for the Safety of Health Products

…revious phase Ib-II trial, we evaluated a sequential regimen of gemcitabine plus nab-paclitaxel (GEMBRAX) followed by FOLFIRINOX (FFX), whi…